Security key
747324101
Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)
CUSIP: 747324101
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 62,130,557
- Total 13F shares
- 8,795,542
- Share change
- +536,621
- Total reported value
- $15,830,945
- Put/Call ratio
- 8.7%
- Price per share
- $1.80
- Number of holders
- 50
- Value change
- +$874,420
- Number of buys
- 15
- Number of sells
- 18
Report period
Q4 2023
Institutions
50
Top holders
10
PYXS full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Pyxis Oncology, Inc. SEC filings
Pyxis Oncology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 747324101
Recent filing periods:
Top shareholders of PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PFIZER INC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
7,032,770
|
$19,410,445 | — | 17 Mar 2023 | |
| Laurion Capital Management LP |
13F
|
Company |
5.1%
|
3,170,803
|
$6,309,898 | — | 30 Sep 2023 | |
| BARCLAYS PLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,477,975
|
$4,869,165 | — | 26 Apr 2022 | |
| Bayer World Investments B.V. |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
2,742,338
|
$3,839,273 | — | 13 Oct 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
1,140,243
|
$2,269,084 | — | 30 Sep 2023 | |
| Cormorant Asset Management, LP |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
1,118,854
|
$1,566,396 | — | 13 Oct 2021 | |
| Jay Feingold |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
747,862
mixed-class rows
|
$1,089,573 | — | 24 Mar 2023 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.67%
|
415,072
|
$826,000 | — | 30 Sep 2023 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.62%
|
382,606
|
$761,386 | — | 30 Sep 2023 | |
| Decheng Capital Management III (Cayman), LLC |
13F
|
Company |
0.53%
|
326,810
|
$650,352 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.49%
|
301,514
|
$600,013 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.46%
|
288,299
|
$573,873 | — | 30 Sep 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.38%
|
236,195
|
$470,028 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.35%
|
216,251
|
$430,000 | — | 30 Sep 2023 | |
| Ken Kobayashi |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
110,878
|
$424,663 | — | 29 Dec 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.25%
|
153,771
|
$306,004 | — | 30 Sep 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.2%
|
125,000
|
$248,750 | — | 30 Sep 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.19%
|
119,813
|
$238,428 | — | 30 Sep 2023 | |
| Ronald Herbst |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
118,674
mixed-class rows
|
$234,796 | — | 07 Oct 2021 | |
| Harvest Investment Services, LLC |
13F
|
Company |
0.18%
|
113,894
|
$226,649 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.16%
|
100,854
|
$200,700 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.13%
|
83,055
|
$165,279 | — | 30 Sep 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.13%
|
80,500
|
$160,195 | — | 30 Sep 2023 | |
| CORNERCAP INVESTMENT COUNSEL INC |
13F
|
Company |
0.12%
|
74,903
|
$149,057 | — | 30 Sep 2023 | |
| Fan Yu |
13F
|
Individual |
0.11%
|
69,303
|
$137,912 | — | 30 Sep 2023 | |
| Ritu Shah |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
31,344
|
$120,048 | — | 07 Oct 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.08%
|
52,746
|
$104,965 | — | 30 Sep 2023 | |
| UNIVERSITY OF CHICAGO |
13F
|
Company |
0.08%
|
48,731
|
$96,975 | — | 30 Sep 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
32,553
|
$64,781 | — | 30 Sep 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
22,556
|
$44,886 | — | 30 Sep 2023 | |
| SCHULHOFF & CO INC |
13F
|
Company |
0.04%
|
22,000
|
$43,780 | — | 30 Sep 2023 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.03%
|
19,996
|
$40,000 | — | 30 Sep 2023 | |
| Cetera Investment Advisers |
13F
|
Company |
0.03%
|
19,260
|
$38,327 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
16,132
|
$32,103 | — | 30 Sep 2023 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.02%
|
13,771
|
$27,404 | — | 30 Sep 2023 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.02%
|
13,312
|
$26,491 | — | 30 Sep 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.02%
|
13,233
|
$26,000 | — | 30 Sep 2023 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.02%
|
12,950
|
$26,000 | — | 30 Sep 2023 | |
| Bleakley Financial Group, LLC |
13F
|
Company |
0.02%
|
11,234
|
$22,356 | — | 30 Sep 2023 | |
| Simplicity Solutions, LLC |
13F
|
Company |
0.02%
|
11,234
|
$22,356 | — | 30 Sep 2023 | |
| Kingsview Wealth Management, LLC |
13F
|
Company |
0.02%
|
10,707
|
$21,307 | — | 30 Sep 2023 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
10,352
|
$20,600 | — | 30 Sep 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
7,786
|
$15,494 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
3,200
|
$6,368 | — | 30 Sep 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
3,070
|
$6,109 | — | 30 Sep 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
3,273
|
$6,000 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,955
|
$5,880 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,508
|
$4,991 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,983
|
$3,946 | — | 30 Sep 2023 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0%
|
1,792
|
$3,567 | — | 30 Sep 2023 |
Institutional Holders of Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) as of Q4 2023
As of 31 Dec 2023,
Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,795,542 shares.
The largest 10 holders included
Laurion Capital Management LP, VANGUARD GROUP INC, abrdn plc, Vestal Point Capital, LP, HHLR ADVISORS, LTD., RENAISSANCE TECHNOLOGIES LLC, Decheng Capital LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
49
Q4 2023 holders
50
Holder diff
1
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.